S
CLVS

SignatureFD’s Clovis Oncology, Inc. CLVS Stock Holding History

SignatureFD’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-195
Closed -$1K – 3392
2021
Q4 		$1K Buy
195
+144
+282% +$532 ﹤0.01% 3060
2021
Q3 		$0 Sell
51
-212
-81% -$1.02K ﹤0.01% 3280
2021
Q2 		$2K Buy
263
+49
+23% +$287 ﹤0.01% 2651
2021
Q1 		$2K Hold
214
– – ﹤0.01% 2563
2020
Q4 		$1K Sell
214
-405
-65% -$2.05K ﹤0.01% 2517
2020
Q3 		$4K Sell
619
-131
-17% -$784 ﹤0.01% 2024
2020
Q2 		$5K Buy
+750
New +$5.68K ﹤0.01% 1849
2019
Q3 		– Sell
-1
Closed – – 2240
2019
Q2 		$0 Sell
1
-1
-50% -$18 ﹤0.01% 2199
2019
Q1 		$0 Buy
+2
New +$50 ﹤0.01% 2088

Other funds holding CLVS

N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

SignatureFD's CLVS Position: Q1 2022 in Review

SignatureFD sold out of Clovis Oncology, Inc. (CLVS) in Q1 2022, closing a stake of 195 shares — an estimated $1K sold.

SignatureFD first reported a position in CLVS in Q1 2019 and held it in 9 quarters. The position peaked at $5K in Q2 2020. 153 funds tracked by Wall St. Rank hold CLVS as of Q1 2022.

  • SignatureFD reported no remaining Clovis Oncology, Inc. position as of Q1 2022 after selling out during the quarter.
  • SignatureFD sold 195 Clovis Oncology, Inc. shares in Q1 2022, an estimated $1K.
  • SignatureFD first reported a position in Clovis Oncology, Inc. in Q1 2019 and held it in 9 quarters.
  • SignatureFD's Clovis Oncology, Inc. position peaked at $5K in Q2 2020.
  • 153 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q1 2022.

Based on SignatureFD's 13F filing for Q1 2022, filed 2 May 2022.